RTSN

Retension Pharmaceuticals Inc

12.21

Oct 13 • 11:03 AM ET +0.89 (7.84%)

Healthcare Biotechnology USA Micro NASD

Index	-
Market Cap	96.21M
Enterprise Value	110.89M
Income	-
Sales	-
Book/sh	-1.89
Cash/sh	1.71
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Oct 09, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	7.13
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.61
Current Ratio	5.61
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	7.53%
SMA50	7.53%
SMA200	7.53%
Trades

Shs Outstand	7.88M
Shs Float	4.73M
Short Float	-
Short Ratio	-
Short Interest	-
52W High	11.79 3.54%
52W Low	9.66 26.37%
Volatility	- -
ATR (14)	1.53
RSI (14)	-
Beta	-
Rel Volume	0.36
Avg Volume	483.41K
Volume	48,505

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	22.07%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	11.32
Price	12.21
Change %	7.84%

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.

Executive ChairmanDr. Michael Joseph Berendt Ph.D.

Chief Financial OfficerMr. Alexander Duke Schwartz M.B.A.

Chief Operations OfficerMs. Sabine Bisson Ph.D.

Chief Regulatory & Compliance OfficerMr. Craig Michael Audet Ph.D.

M.D.Dr. Alison D. Schecter FACC

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RTSN

Retension Pharmaceuticals Inc

Upgrade your Finviz experience